Key facts
- This page summarizes Patrick Klein's Form 4 filing for QuidelOrtho Corp (QDEL).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 16 Feb 2024, 16:08.
Patrick Klein - 08 Feb 2024 Form 4 Insider Report for QuidelOrtho Corp (QDEL)
- Reporting relationship
- Chief Administrative Officer
- Issuer ticker
- QDEL
- Reported as of
- 08 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2024, 16:08:19 UTC
- Prior SEC filing
- 25 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Phillip S. Askim, attorney-in-fact for Patrick Klein
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Patrick Klein filed Form 4 for QuidelOrtho Corp (QDEL) on 16 Feb 2024.
Change
- Previous filing in this sequence was filed on 25 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QDEL
transaction
Derivative
Restricted Stock Units (Converted)
Award
- Transaction value
- $0
- Shares
- +839
- Change %
- Price
- $0.000000
- Shares after
- 839
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 839
- Exercise price
- Footnotes
- F1, F2, F3
QDEL
transaction
Derivative
Restricted Stock Units (Premium)
Award
- Transaction value
- $0
- Shares
- +251
- Change %
- Price
- $0.000000
- Shares after
- 251
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 251
- Exercise price
- Footnotes
- F1, F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
Footnote F2
The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule.
Footnote F3
The restricted stock units vested on February 8, 2024.
Footnote F4
The restricted stock units vest on February 8, 2025.